4.8 Article

Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy

Related references

Note: Only part of the references are listed.
Review Cardiac & Cardiovascular Systems

Insulin-resistant cardiomyopathy

Ronald M. Witteles et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)

Review Cardiac & Cardiovascular Systems

Metabolic mechanisms in heart failure

Houman Ashrafian et al.

CIRCULATION (2007)

Review Medicine, General & Internal

Mechanisms of disease - The failing heart - An engine out of fuel

Stefan Neubauer

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Review Cardiac & Cardiovascular Systems

Emerging therapies for the management of decompensated heart failure - From bench to bedside

Emil M. deGoma et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)

Article Cardiac & Cardiovascular Systems

Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure

Helena Tuunanen et al.

CIRCULATION (2006)

Article Cardiac & Cardiovascular Systems

A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure

Gabriele Fragasso et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)

Article Endocrinology & Metabolism

Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy

LD Monti et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)

Article Cardiac & Cardiovascular Systems

Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure

W Doehner et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)

Article Cardiac & Cardiovascular Systems

The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy

LA Nikolaidis et al.

CARDIOVASCULAR RESEARCH (2004)

Article Cardiac & Cardiovascular Systems

Insulin resistance in idiopathic dilated cardiomyopathy - A possible etiologic link

RM Witteles et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)

Article Cardiac & Cardiovascular Systems

Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy

VG Dávila-Román et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)

Article Endocrinology & Metabolism

Myocardial fatty acid oxidation in patients with impaired glucose tolerance

J Knuuti et al.

DIABETOLOGIA (2001)